On October 2, 2026, a status update was recorded for the clinical trial titled "Tocotrienols for Obesity of Postmenopausal Women," registered as NCT03705845. The trial is listed as Phase 1/Phase 2. Its current status is active, not recruiting. This means the study is ongoing but is not currently enrolling additional participants. The trial record does not include reported results as of this update. No outcome data, efficacy claims, or safety findings were provided alongside this status change. The update reflects only the recruitment and phase status of the study at this time. Leptin is referenced in connection with this research area, given its established role in obesity related studies and regulatory approval as a compound. This brief reports only the status information made available through the trial registry entry. Readers interested in the broader context of this research, including the design and goals of the trial, can consult the original registry listing for further detail. For general background on leptin, including its approved uses and ongoing areas of study, readers can refer to the compound overview.
Trial Update: "Tocotrienols for Obesity of Postmenopausal Women"
Source: https://clinicaltrials.gov/study/NCT03705845